Amsterdam-based medical device company Koninklijke Philips N.V. (Philips) agreed last Thursday to resolve its Foreign Corrupt Practices Act (FCPA) enforcement action by paying the SEC $62m for violations that occurred in China.
The SEC charged Philips in an administrative order with violating the FCPA’s books and records and
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day